Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEstrogen and related hormone effects · Pharmacogenetics and Drug Metabolism · Cancer, Hypoxia, and Metabolism
The Funding statement is incorrect. The publisher apologizes for the error. The complete, correct Funding statement is: This work has been supported partially by a grant from Fundación de Investigación Médica Mutua Madrileña (ref number AP27072008), a grant from Universidad Europea de Madrid (project number 2013/UEM31) and by the help of Cátedra Florencio Tejerina-UEM in blood sample collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Romero-Lorca A, Novillo A, Gaibar M, Bandrés F, Fernández-Santander A (2015) Impacts of the Glucuronidase Genotypes UGT 1A 4, UGT 2B 7, UGT 2B 15 and UGT 2B 17 on Tamoxifen Metabolism in Breast Cancer Patients. P Lo S ONE 10(7): e 0132269 doi: 10.1371/journal.pone.0132269 2617623410.1371/journal.pone.0132269 PMC 4503404 · doi ↗ · pubmed ↗